Dr Jeffrey Curtis discusses the web-based survey that identified unmet needs perceived by patients with rheumatoid arthritis.
Researchers sought to identify the molecular basis of the overlap between rheumatoid arthritis-associated interstitial lung disease and idiopathic pulmonary fibrosis by comparative profiling of serum proteins.
Serum interleukin (IL)-35 levels are associated with bone loss and may represent a novel therapeutic target for postmenopausal women with rheumatoid arthritis.
Researchers investigated the role of interleukin-1 inhibition in improving glycemic and inflammatory parameters in patients with rheumatoid arthritis and type 2 diabetes.
Increases in functional connectivity between pro-nociceptive brain areas may correlate with higher levels of peripheral inflammation in individuals with rheumatoid arthritis and comorbid fibromyalgia.